Navigation Links
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
Date:4/24/2008

PALO ALTO, Calif., April 24 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending approval of ranolazine in the European Union (EU) for the treatment of chronic angina.

Following this positive recommendation from the CHMP, CV Therapeutics expects the European Commission to issue full marketing authorization for ranolazine by the end of June. The brand name for ranolazine in the product labeling is Latixa(TM).

The approved indication states that ranolazine "is indicated as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists)."

The labeling reflects data from the MERLIN TIMI-36 and other recently reported studies, including data showing statistically significant reductions in ventricular arrhythmias with ranolazine. The labeling also notes that the ability of ranolazine to reduce calcium overload is expected to improve myocardial relaxation and decrease left ventricular diastolic stiffness. The doses of the product in the EU will be 375 mg, 500 mg and 750 mg twice daily.

"This positive opinion from the CHMP brings ranolazine significantly closer to physicians and patients in Europe for the treatment of chronic angina," said Louis G. Lange, M.D., Ph.D., chairman and chief executive officer of CV Therapeutics. "The strong first-in-class product labeling should position ranolazine very favorably with potential partners and allow for broad patient acceptance and premium pricing in the E
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Cardinal Health has been ... for Executive Women " by the National Association for ... and promote successful women. "We,re counting ... top companies and are happy to find that companies ... Spence , NAFE President. "The 2015 NAFE Top Companies ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of SNS Research,s new report ... - Opportunities, Challenges, Strategies & Forecasts" to ... drug is a pharmaceutical product, usually intended to ... manufactured without a license from the innovator company ...
(Date:3/3/2015)...  MabVax Therapeutics (OTCQB: MBVX), a cancer diagnostic and immunotherapy ... President and CEO, will be presenting at the 27 th ... 12, 2015 at the Ritz Carlton in Laguna ... scheduled for Wednesday, March 11 th , at 11:30 AM ... the Investor Relations section of the Company,s website at ...
Breaking Medicine Technology:Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 2Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 3Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 2Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 3Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 5Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 6
... Mich., June 29, 2011 Perrigo Company (Nasdaq: ... to finalize  the regulatory approvals necessary to complete ... privately-held, Minneapolis-based pharmaceutical manufacturer of generic Rx pharmaceuticals ... Chairman and CEO Joseph C. Papa stated, "We ...
... UBM Canon,s leading brand, Japan Medical Design & Manufacturing Technology ... its new Japanese-language website with enhanced content and functionality at ... users to find the resources and information they are seeking as ... , JMDMT , and CMDM . "We,ve ...
Cached Medicine Technology:Perrigo Provides Update on Acquisition of Paddock Labs 2Perrigo Provides Update on Acquisition of Paddock Labs 3UBM Canon Announces New Japanese-Language Website for Japan Medical Design & Manufacturing Technology: www.jmdmt.com 2
(Date:3/3/2015)... RATON, Fla - (March 3, 2015) (PRWEB) March 03, ... Class Vacations, Inc. (FCV), an innovator in the travel ... step in his trailblazing expansion plan. To fulfill his ... with the addition of 400 fun, exciting and well-compensated ... Florida headquarters and a news sales center planned for ...
(Date:3/3/2015)... 03, 2015 March 3, 2015, My Positive ... episode. The episode was a unique one, not just because ... because it featured two men who were both faced with ... the beginning of the episode, Deierlein said to Collins, “I ... radio show, but I’m very excited that you could join ...
(Date:3/3/2015)... New Zealand and Rockville, Maryland (PRWEB) March 03, ... selected Cornerstone Communications, LTD as its North American ... Cornerstone was awarded the Manuka Lab contract because ... and consumer verticals. , Headquartered in Auckland, New ... company focused on providing clients effective, certified natural ...
(Date:3/3/2015)... 03, 2015 Using an “intelligent,” rather ... Medicare Part D prescription drug coverage plans could save ... new University of Pittsburgh Graduate School of Public Health ... the March issue of the journal Health Affairs and ... have saved more than $5 billion in its Part ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Claflin ... the Department of Veterans Affairs has signed a new, ... March 1, 2015. , Under the contract, the ... such as the U.S. Military, Indian Health Services, National ... local government entities with competitive pricing for hospital equipment ...
Breaking Medicine News(10 mins):Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2
... dyslexic brain may have problems in forming perception categories for// ... lead to the dyslexics finding it difficult to filter out ... front of them. ,The research by the scientists from ... in the nature of the workings of a dyslexic brain. ...
... by trained health workers can help in early// detection of ... rate. ,A research done by scientists from Kerala, India, ... people for oral cancer in order to provide early medical ... ,Oral cancer is the growth of malignant tissues or ...
... It is possible to lose knee lubrication following an injury ... ,Researchers from University of Rhode Island had identified a ... happened to a knee after a knee injury, in order ... factor for arthritis. ,Although knee injury is considered to ...
... bacterial infections from the bacteria Pseudomonas.// Treatment for ... suggests that antibiotic treatment may encourage the bacteria ... ,Cystic fibrosis is disease of genetic origin ... that affects the lungs and can cause severe ...
... children are more exposed to indoor allergens// at their ... are commonly found indoor include bacteria, molds, mildew, viruses, ... and pollens. These may cause allergic reactions like allergic ... of the symptoms experienced by people in presence of ...
... of chicken pox vaccine to// effectively control the painful condition ... is the condition that gets symptoms of rashes or blisters ... and numbness on the area. There may be fever with ... chicken pox and is caused by the same virus varicella-zoster. ...
Cached Medicine News:
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... deliver particulate humidity in the 3 to ... patients. For your convenience, Thera-Mist® nebulizers may ... sterile water., ,The P30000N, for normal ... with a total flow range of 68-24 ...
... be held at angles up to 45° without ... spill column, finger grooves for a non-slip gripping ... feet of regular oxygen tubing. The large ... and sustain optimum mist concentration at every setting. ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
Medicine Products: